BioRestorative Therapies (FRA:9OF) Short Interest


FRA:9OF BioRestorative Therapies Inc FRA:9OF
51 GF Score
Price €0.31
GF Value €1.26
Valuation Possible Value Trap
! 3 Warning Signs
View Full Analysis

What is BioRestorative Therapies Short Interest?

Short Interest can be expressed as a percentage by dividing the number of shares sold short by the total number of outstanding shares.

Due to the license agreement change with our data vendor, Short Interest related data on GuruFocus will no longer be updated. Existing data will remain as-is, while new data will not be available, except for certain Australian and Canadian stocks.

FRA:9OF vs CVKD, JSPR, APRE: Short Interest Comparison

For the Biotechnology subindustry, BioRestorative Therapies's Short Interest, along with its competitors' market caps and Short Interest data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

BioRestorative Therapies Short Interest vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, BioRestorative Therapies's Short Interest distribution charts can be found below:

* The bar in red indicates where BioRestorative Therapies's Short Interest falls into.


FRA:9OF
51GF Score
BioRestorative Therapies Inc FRA:9OF
Short Interest is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is BioRestorative Therapies (FRA:9OF) Overvalued in 2026?

Based on GuruFocus' analysis, BioRestorative Therapies stock appears to be undervalued. The current stock price of €0.31 is trading 75.1% below its estimated GF Value™ of €1.26. GuruFocus considers BioRestorative Therapies to be Possible Value Trap.

Key valuation signals for FRA:9OF:

  • Short Interest:
  • GF Value™: €1.26 vs. price of €0.31 (75.1% below fair value)
  • GF Score™: 51/100 with 3 warning signs

No single metric tells the full story. See the FRA:9OF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

BioRestorative Therapies Business Description

Other Exchanges BRTX:USA
Address 40 Marcus Drive, Suite One, Melville, NY, USA, 11747
BioRestorative Therapies Inc is engaged in developing therapeutic products using cell and tissue protocols, involving adult stem cells. The company is pursuing its Disc/Spine Program with initial investigational therapeutic product being called BRTX-100 in the treatment of chronic cervical discogenic pain. The technology is an stem cell injection procedure that may offer relief from lower back pain, buttock and leg pain, and numbness and tingling in the leg and foot. It is also developing ThermoStem Program, a pre-clinical program which involves the use of brown adipose (fat) in connection with the cell-based treatment of type 2 diabetes and obesity as well as hypertension, other metabolic disorders and cardiac deficiencies.
51GF Score

Get the complete analysis for FRA:9OF

Short Interest is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€0.31
Price
€1.26
GF Value